Auditing matters

Dutch gene therapy play uniQure has nominated Jack Kaye to its Board of Directors. Kaye will also chair the uniQure’s Audit Committee.

ADVERTISEMENT

Kaye, who holds a Bachelor of Business Administration from Baruch College in New York and is a Certified Public Accountant, is currently chairman of the Audit Committee and a member of the Compensation Committee of Dyadic International. Previously, he served as chairman of the Audit Committee of Keryx Biopharmaceuticals. From 1978 till 2006, he was a partner of international accounting, tax and consulting firm Deloitte.

uniQure is intending to transition from the current two-tier Supervisory Board and Management Board structure to a single Board of Directors with executive and non-executive members.

YOU DON`T WANT TO MISS ANYTHING?

Sign up for our newsletter!